IBN
  



  














    
  


  
Închide

Afiliat la Gossamer Bio, Inc., San Diego

2022 - 2

Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply
Danese Silvio , Levesque Barrett G. , Feagan Brian Gordon , Jucov Alina , Bhandari Bal Raj , Pai Rish K. , Taylor Meadows Kristen , Kirby Brian J. , Bruey Jean Marie , Olson Allan David , Osterhout Robin E. , van Biene Courtney , Ford Julia , Aranda Richard , Raghupathi Kartik , Sandborn William J.
Alimentary Pharmacology and Therapeutics
Nr. 6(55) / 2022 / ISSN 0269-2813 / ISSNe 1365-2036
Disponibil online 17 March, 2022
-----------------------------------------------------------------------------------------------------------------------------------
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis
Danese Silvio , Levesque Barrett G. , Feagan Brian Gordon , Jucov Alina , Bhandari Bal Raj , Pai Rish K. , Taylor Meadows Kristen , Kirby Brian J. , Bruey Jean Marie , Olson Allan David , Osterhout Robin E. , van Biene Courtney , Ford Julia , Aranda Richard , Raghupathi Kartik , Sandborn William J.
Alimentary Pharmacology and Therapeutics
Nr. 4(55) / 2022 / ISSN 0269-2813 / ISSNe 1365-2036
Disponibil online 2 March, 2022
-----------------------------------------------------------------------------------------------------------------------------------

2020 - 1

Safety, pharmacokinetic, biomarker, histologic, and rectal bleeding activity following treatment with the GUT-targeted, PHD-inhibitor and HIF-1α stabilizer GB004 in a phase 1b trial in MILD-to-moderate ulcerative colitis
Sandborn William J. , Feagan Brian Gordon , Danese Silvio , Jucov Alina , Bhandari Bal Raj , Raghupathi Kartik , Olson Allan David , van Biene Courtney , Opiteck G. , Ford Julia , Aranda Richard , Levesque Barrett G.
United European Gastroenterology Journal
Nr. 8(8) / 2020 / ISSN 2050-6406 / ISSNe 2050-6414
Disponibil online 11 April, 2024
-----------------------------------------------------------------------------------------------------------------------------------
 
 

1-3 of 3